We recovered a confidential sum in a wrongful death case against a company that operated clinical drug trials. Our clients’ decedent took his own life immediately after completing the in-patient phase of a clinical trial for a psychotropic drug. We believe that the case settled because we established that the company running the drug trial and its lead investigator failed to obtain proper informed consent for the man’s participation in the trial and because they violated safety rules when they discharged him from in-patient observation without notifying any of his family members that he was going to be released under his own supervision.